AEQUS
AEQUSVerifiedAEQUS is a publicly traded security listed on the NSE/BSE exchange.
Stock Snapshot & Key Numbers — AEQUS
Verified Daily CloseOfficial closing price, 1-year price range, valuation multiples, and market value from exchange records.
AEQUS (AEQUS) is a Indian equity security listed on the NSE/BSE with ISIN BSE:544634. As of the last recorded market session on Close on 16 Oct 2026, the stock closed at ₹262.20, recording a +3.00 (+1.16%) advance from its previous close of ₹259.20. Over the trailing 52-week trading cycle, AEQUS has traded between a 52-week low of ₹115.11 and a 52-week high of ₹288.15, establishing its annual trading channel. In historical performance, AEQUS has gained 73.31% over the past 1 year. Period returns across standard measurement intervals include: 1-week: -4.13%, 1-month: +18.81%, 6-month: +63.64%, 1-year: +73.31%, 3-year: +73.31%, 5-year: +73.31%. Daily reported trading volume reached 23,10,844 equity shares. On key valuation multiples as of 11 Oct 2026, the company trades at a trailing price-to-earnings (P/E) multiple of not meaningful (negative earnings) and a price-to-book (P/B) ratio of 11.1x, with a trailing dividend yield of 0.00%. Its market capitalization stands at ₹17,910.26 Cr. The company is categorized under the Diversified Indian Equities sector and Public Market Listed Security industry within the Indian equities universe.
Price Chart
Trading Multiples & Ranges
Price boundaries and liquidity distribution.
How Outside Factors Affect This Stock (Market, Crude Oil & Currency)
How closely this stock moved with the broader market index, crude oil, and the exchange rate over the past year.
| Factor / Benchmark | 1Y Beta (Sensitivity) | 1Y Correlation (-1 to +1) | What This Means |
|---|---|---|---|
| NIFTY 50 | +0.68 | +0.18 | Trailing 1Y historical sensitivity: a 1% move in NIFTY 50 coincided with a +0.68% co-movement (correlation: 0.18). Descriptive historical relationship, not predictive. |
| USD / INR | -0.65 | -0.09 | Trailing 1Y historical sensitivity: a 1% move in USD / INR coincided with a -0.65% co-movement (correlation: -0.09). Descriptive historical relationship, not predictive. |
| Brent Crude Oil | -0.08 | -0.09 | Trailing 1Y historical sensitivity: a 1% move in Brent Crude Oil coincided with a -0.08% co-movement (correlation: -0.09). Descriptive historical relationship, not predictive. |
| US 10Y Treasury Yield | +0.20 | +0.05 | Trailing 1Y historical sensitivity: a 1% move in US 10Y Treasury Yield coincided with a +0.20% co-movement (correlation: 0.05). Descriptive historical relationship, not predictive. |
How to read Beta & Correlation ( Beta > 1 = wider swings than market; < 1 = calmer )▾
Sensitivities measure historical 1-year regression beta and correlation across paired daily trading sessions over the past 252 trading days. Past relationships can shift over time and do not guarantee future co-movement.
Trailing Returns Breakdown
Calendar-aligned historical percentage performance across standard market windows.
| Period | Start Price | Current Price | Return (%) |
|---|---|---|---|
| 1 Week | ₹273.50 | ₹262.20 | -4.13% |
| 15 Days | ₹275.05 | ₹262.20 | -4.67% |
| 1 Month | ₹220.68 | ₹262.20 | +18.81% |
| 3 Months | ₹234.69 | ₹262.20 | +11.72% |
| 6 Months | ₹160.23 | ₹262.20 | +63.64% |
| 1 Year | ₹151.29 | ₹262.20 | +73.31% |
| 3 Years | ₹151.29 | ₹262.20 | +73.31% |
| 5 Years | ₹151.29 | ₹262.20 | +73.31% |
Price Swings & Biggest Historical Drops
How much this stock typically fluctuates and its largest peak-to-bottom drops over 1 and 5 years.
Calendar-Year Historical Performance
Annual performance breakdown comparing first and last closing sessions of each calendar year.
| Calendar Year | Start Close | End Close | Annual Return | Trajectory Bar |
|---|---|---|---|---|
| CY 2026 | ₹138.19 | ₹262.20 | +89.7% | |
| CY 2025 | ₹151.29 | ₹137.49 | -9.1% |
Historical Investment Simulator
Factual simulation of past returns in AEQUS (AEQUS) using real recorded closing prices.
Corporate Actions History
No dividend or stock split distributions recorded in historical feeds for AEQUS.
Recent News & Official Exchange Announcements
Official exchange filings, order wins, and company updates. Click any announcement to see how it affects the business on the right.
Aequs shares rise up to 6% on Rs 660 crore capex budget for FY27 - Moneycontrol.com
Aequs shares rise up to 6% on Rs 660 crore capex budget for FY27 Moneycontrol.com
Aequs jumps 5% as Nuvama sees up to 91% upside for the smallcap defence stock - Moneycontrol.com
Aequs jumps 5% as Nuvama sees up to 91% upside for the smallcap defence stock Moneycontrol.com
Aequs tumbles 10% after Q4 Ebitda miss; JM Financial downgrades to 'Reduce' - Business Standard
Aequs tumbles 10% after Q4 Ebitda miss; JM Financial downgrades to 'Reduce' Business Standard
Aequs Limited's (NSE:AEQUS) Path To Profitability - Simply Wall Street
Aequs Limited's (NSE:AEQUS) Path To Profitability Simply Wall Street
Aequs Q2 Results FY27: Date, Expectations and Watchlist - Univest
Aequs Q2 Results FY27: Date, Expectations and Watchlist Univest
Why This Matters for the Business
Plain-English breakdown of how the selected announcement connects to revenue, costs, and business drivers.
Capital expenditure deployment expands operating throughput and market share in core commercial segments.
- •Transaction / financial magnitude identified at ₹660 Cr
- •Direct quantitative change registered at 6%
- •Capital investment targeted at expanding manufacturing and throughput capacity
Volume throughput absorbs fixed manufacturing plant overheads, supporting operating EBITDA margins and cash generation across diversified indian equities units.
Identified project outlay of ₹660 Cr secures forward multi-quarter top-line visibility.
At-a-Glance Health & Momentum Check
Recent exchange filings and reported financial statements show healthy alignment between revenue growth, operating cash flow, and improving profit margins.
Peer & Sector Comparison — Next Research Steps
Exit points and comparative equity universe: same-sector peers, shared macro sensitivity betas, and your watchlist.
Common Questions About AEQUS (AEQUS)
Key facts on AEQUS share price, historical returns, valuation ratios, and past SIP performance.
What is the current share price and 52-week range of AEQUS (AEQUS)?
As of 16 Oct 2026, the official closing share price of AEQUS (AEQUS) on NSE/BSE is ₹262.20 (+1.16% vs the previous close). Over the past 52 weeks, AEQUS has traded between a low of ₹115.11 and a high of ₹288.15, with a reported market capitalization of ₹17,910.26 Cr.
What are the historical returns of AEQUS (AEQUS)?
Based on split-adjusted closing prices through 16 Oct 2026, AEQUS (AEQUS) recorded the following trailing price returns: 1 Week: -4.13% (from ₹273.50 to ₹262.20); 15 Days: -4.67% (from ₹275.05 to ₹262.20); 1 Month: +18.81% (from ₹220.68 to ₹262.20); 3 Months: +11.72% (from ₹234.69 to ₹262.20); 6 Months: +63.64% (from ₹160.23 to ₹262.20); 1 Year: +73.31% (from ₹151.29 to ₹262.20); 3 Years: +73.31% (from ₹151.29 to ₹262.20); 5 Years: +73.31% (from ₹151.29 to ₹262.20). Past performance reflects historical exchange records and does not predict future returns.
What is the P/E ratio, P/B ratio, and dividend yield of AEQUS (AEQUS)?
AEQUS (AEQUS) currently trades at a trailing Price-to-Earnings (P/E) ratio of not applicable (or negative trailing earnings), a Price-to-Book (P/B) ratio of 11.1x, and a trailing 12-month dividend yield of 0.00%. It operates in the Diversified Indian Equities sector (Public Market Listed Security).
How much would a past lump-sum or monthly SIP investment in AEQUS have grown?
Based on historical closing prices for AEQUS (AEQUS): A one-time lump-sum investment of ₹1,00,000.00 held for 5 years would be worth ₹1,73,309.55 (+73.3% total return, 91.2% CAGR), while a monthly SIP of ₹10,000.00 over 5 years (total invested: ₹1,10,000.00) would be worth ₹1,65,525.38 (+50.5% absolute return). You can test custom amounts and holding periods in the interactive calculator above.
Official Corporate Perspective
Authorized Investor Relations officers may submit authenticated context or coordinate with our research team.